Browsing Tag
T-Cell lymphoma
7 posts
Prescient Therapeutics gets FDA orphan drug status for PTX-100 in PTCL
Prescient Therapeutics has secured the orphan drug designation for its PTX-100 compound from the US Food and Drug…
Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn
US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company,…
Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL
Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of…
Bioniz Therapeutics reports positive phase 1/2 trial data for BNZ-1 in treating relapsed/refractory CTCL
Bioniz Therapeutics, a leading player in the field of peptide-based therapeutics, has revealed promising data from a phase…
Takeda gets extended EC approval for ADCETRIS in sALCL
Takeda Pharmaceutical has secured extended approval for ADCETRIS (brentuximab vedotin) in the European Union to include the treatment…
Soligenix all set to begin FLASH clinical trial for SGX301 in CTCL
US biopharma company Soligenix has wrapped up enrolling patients for its phase 3 Fluorescent Light Activated Synthetic Hypericin…
Verastem gets FDA orphan drug status for COPIKTRA for T-Cell lymphoma
Verastem Oncology has secured orphan drug designation for COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K), from…